Top Markets
#1 Akedo Akedo +59.32%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +43.06%
#5 Black Phoenix Black Phoenix +34.58%
#6 τemplar τemplar +22.94%
#7 Cap Cap +19.28%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.53%
#9 Cross Cross +17.30%
#10 Bitway Bitway +15.59%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Classement en actions #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Prix de l'action
$0.08765138
Dernière synchronisation: 2025-12-23
Capitalisation boursière
$1.11M
Changement (1 jour)
0.45%
Changement (1 an)
-28.78%
Pays
CA
Échange Psyence Group Inc. (PSYG)

Catégorie

Healthcare
Ratio P/S pour Psyence Group Inc. (PSYG)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Psyence Group Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Psyence Group Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 -
US